Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.

Stephen P Richman, G. M. Mavligit, R. Wolk, J. U. Gutterman, E. M. Hersh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Because of the serious toxicity of intralesionally injected BCG, including high fever, local ulceration, chronic drainage, and disseminated BCG disease, 13 patients received local BCG immunotherapy by the new approach of epilesional scarification. Three patients had complete responses, four had partial responses, and six had no response. Toxic reactions were minimal compared to those reported for intralesionally given BCG.

Original languageEnglish
Pages (from-to)1233-1235
Number of pages3
JournalJournal of the American Medical Association
Volume234
Issue number12
DOIs
StatePublished - Dec 22 1975
Externally publishedYes

Fingerprint

Mycobacterium bovis
Immunotherapy
Poisons
Drainage
Fever

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG. / Richman, Stephen P; Mavligit, G. M.; Wolk, R.; Gutterman, J. U.; Hersh, E. M.

In: Journal of the American Medical Association, Vol. 234, No. 12, 22.12.1975, p. 1233-1235.

Research output: Contribution to journalArticle

Richman, Stephen P ; Mavligit, G. M. ; Wolk, R. ; Gutterman, J. U. ; Hersh, E. M. / Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG. In: Journal of the American Medical Association. 1975 ; Vol. 234, No. 12. pp. 1233-1235.
@article{bd830398e88c448ebee8e7f1c179ec4f,
title = "Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.",
abstract = "Because of the serious toxicity of intralesionally injected BCG, including high fever, local ulceration, chronic drainage, and disseminated BCG disease, 13 patients received local BCG immunotherapy by the new approach of epilesional scarification. Three patients had complete responses, four had partial responses, and six had no response. Toxic reactions were minimal compared to those reported for intralesionally given BCG.",
author = "Richman, {Stephen P} and Mavligit, {G. M.} and R. Wolk and Gutterman, {J. U.} and Hersh, {E. M.}",
year = "1975",
month = "12",
day = "22",
doi = "10.1001/jama.234.12.1233",
language = "English",
volume = "234",
pages = "1233--1235",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.

AU - Richman, Stephen P

AU - Mavligit, G. M.

AU - Wolk, R.

AU - Gutterman, J. U.

AU - Hersh, E. M.

PY - 1975/12/22

Y1 - 1975/12/22

N2 - Because of the serious toxicity of intralesionally injected BCG, including high fever, local ulceration, chronic drainage, and disseminated BCG disease, 13 patients received local BCG immunotherapy by the new approach of epilesional scarification. Three patients had complete responses, four had partial responses, and six had no response. Toxic reactions were minimal compared to those reported for intralesionally given BCG.

AB - Because of the serious toxicity of intralesionally injected BCG, including high fever, local ulceration, chronic drainage, and disseminated BCG disease, 13 patients received local BCG immunotherapy by the new approach of epilesional scarification. Three patients had complete responses, four had partial responses, and six had no response. Toxic reactions were minimal compared to those reported for intralesionally given BCG.

UR - http://www.scopus.com/inward/record.url?scp=0016859966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016859966&partnerID=8YFLogxK

U2 - 10.1001/jama.234.12.1233

DO - 10.1001/jama.234.12.1233

M3 - Article

C2 - 1242748

AN - SCOPUS:0016859966

VL - 234

SP - 1233

EP - 1235

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 12

ER -